Sleep Apnea, Obstructive: Clinical Trials

95 trials for Sleep Apnea, Obstructive, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

52 completed, 14 terminated, 14 unknown, 7 recruiting. 95 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 495Completed 52, Terminated 14, Unknown 14, Recruiting 7, Withdrawn 5, Active not recruiting 2, Not yet recruiting 1

Follow Sleep Apnea, Obstructive: new trials by email Literature Review of Sleep Apnea, Obstructive trials Research Report on Sleep Apnea, Obstructive

Trials (filtered) newest first · largest first

All 95 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Comparative Effectiveness Study of Positive Airway Pressure (PAP) Therapy, Dental Device, and Atomoxetine-Oxybutynin for Treatment of Obstructive Sleep Apnea in Adults
Positive airway pressure (PAP) therapy, Sleep dental device, Atomoxetine-oxybutynin - Obstructive Sleep Apnea (OSA)
Phase 4RecruitingSairam Parthasarathy24002026-09-042026-10-19
INFORMing Patients With Oximetry Data to Improve MAD Engagement
Narval MRD device, MyNarval intervention (Narval CC MAD + O2 ring + MyNarval smartphone application), - Obstructive Sleep Apnea (OSA)
Phase 4Not yet recruitingResMed1202026-06-012026-05-04
Endotype DIrected Treatment for OSA in Down Syndrome
ato-oxy, Oxygen - Obstructive Sleep Apnea (OSA), Down Syndrome
Phase 4RecruitingUniversity of Arizona2002026-03-142026-09-03
Combination of Remimazolam and Propofol During Drug-induced Sleep Endoscopy
Remimazolam and Propofol, Propofol, Midazolam and propofol - Sedative Effect During Drug-induced Sleep Endoscopy, Obstructive Sleep Apnea (OSA)
Phase 4Active not recruitingDan Liu1742025-03-012026-02-24
Mini-dose Dexmedetomidine-Esketamine Supplemented Analgesia in Patients at High-risk of OSA
Dexmedetomidine-esketamine combination, Placebo - Obstructive Sleep Apnea, Surgery
Phase 4CompletedPeking University First Hospital1002024-09-112026-09-04
Muscle Relaxation for Pediatric Adenotonsillectomy
Rocuronium, Sugammadex, Anesthesia without neuromuscular blockade - Tonsillectomy
Phase 4CompletedUniversity of Texas Southwestern Medical Center1722024-04-102025-07-28
Impact GLP-1 Agonists Following Bariatric
GLP-1 receptor agonist - Morbid Obesity, Metabolic Syndrome
Phase 4RecruitingUniversity of Missouri-Columbia1502024-02-012026-10-21
CPAP Effect on the Polycythemia in Patients With Obstructive Sleep Apnea
Continuous positive airway pressure, Conventional pharmacological treatment, Sleep ,diet and life style recomendations - Sleep Apnea, Obstructive, Polycythemia
Phase 4RecruitingHospital Universitario Ramon y Cajal1822023-11-012025-09-17
Zolpidem on CPAP Acclimatization in OSA
Zolpidem, Placebo - Obstructive Sleep Apnea
Phase 4UnknownSiriraj Hospital302023-10-152023-10-16
Effect of Eszopiclone on Adherence to CPAP and Severity of Insomnia in Patients With COMISA
Eszopiclone 3 mg, Placebo - Obstructive Sleep Apnea, Insomnia
Phase 4CompletedUniversity of Sao Paulo General Hospital602023-08-242026-05-29
Melatonin's Effect on Nighttime Blood Pressure and Sleep in OSA Patients (MEBP-OSA)
Melatonin 3 MG Oral Tablet - Obstructive Sleep Apnea of Adult
Phase 4RecruitingInstituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran502023-06-222026-04-01
Evaluation of Trazodone in OSA-MCI
Trazodone, Placebo - Mild Cognitive Impairment, Obstructive Sleep Apnea
Phase 4Active not recruitingChinese University of Hong Kong1342022-05-102026-01-06
Dental Appliance to Treat SDB in Children
Vivos Grow/Vivos Way Device - Snoring, Apnea, Obstructive
Phase 4UnknownVivos BioTechnologies, Inc.502022-05-032022-12-22
Spironolactone to Improve Apnea and Cardiovascular Markers in Obstructive Sleep Apnea Patients
Spironolactone, Placebo - Obstructive Sleep Apnea
Phase 4WithdrawnUniversity of Michigan2022-03-012022-04-19
Applying Best Clinical Practices to Patients at High Risk of Respiratory Complications
Sugammadex 100 MG/ML [Bridion] - Respiratory Complication, Obstructive Sleep Apnea
Phase 4CompletedUniversity of California, Los Angeles122482022-02-182025-07-29
Ketorolac on Postoperative Pain Reduction in Pediatric Patients with Adenotonsillectomy
Ketorolac - Adenotonsillar Hypertrophy, Obstructive Sleep Apnea
Phase 4CompletedSt. Louis University1422022-02-082025-02-03
First Line Obstructive Sleep Apnea Treatment Study
Mandibular advancement device (MAD), Continuous positive airway pressure (CPAP) - Obstructive Sleep Apnea
Phase 4CompletedUniversity Hospital, Antwerp1362021-11-092025-02-14
Solriamfetol's Effect on Cognitive Health in Apnea Participants During a Randomized Placebo-controlled Study
Solriamfetol, Placebo - Excessive Daytime Sleepiness, Obstructive Sleep Apnea
Phase 4CompletedAxsome Therapeutics, Inc.592021-05-172026-01-26
Optimal Dosage of Acetazolamide for OSA Treatment
Acetazolamide, Placebo - Obstructive Sleep Apnea
Phase 4CompletedUniversity Hospital, Antwerp912021-04-202025-09-24
Dexmedetomidine Supplemented Analgesia in Patients at High-risk of Obstructive Sleep Apnea
Dexmedetomidine, Placebo - Obstructive Sleep Apnea, Analgesia
Phase 4CompletedPeking University First Hospital1522021-01-292022-12-13

Showing 20 of 95. Sign in to see all of them.

Narrower conditions

Sleep Apnea Syndromes (19)  ·  Hypertension (7)  ·  Apnea (5)  ·  Disorders of Excessive Somnolence (4)  ·  Hypoxia (4)  ·  Agnosia (3)  ·  Snoring (3)  ·  Cardiovascular Diseases (2)  ·  Metabolic Syndrome (2)  ·  Obesity (2)  ·  Obesity, Morbid (2)  ·  Pain, Postoperative (2)  ·  Sleep Initiation and Maintenance Disorders (2)  ·  Sleep Wake Disorders (2)

Broader conditions

Dyssomnias (95)  ·  Nervous System Diseases (95)  ·  Respiration Disorders (95)  ·  Respiratory Tract Diseases (95)  ·  Sleep Disorders, Intrinsic (95)  ·  Sleep Wake Disorders (93)  ·  Apnea (90)  ·  Sleep Apnea Syndromes (76)  ·  Pathological Conditions, Signs and Symptoms (28)  ·  Signs and Symptoms (23)  ·  Cardiovascular Diseases (12)  ·  Mental Disorders (12)  ·  Vascular Diseases (12)  ·  Neurologic Manifestations (11)  ·  Signs and Symptoms, Respiratory (9)

Interventions

Continuous Positive Airway Pressure (10)  ·  Dexmedetomidine (5)  ·  Propofol (5)  ·  Acetazolamide (4)  ·  Occlusal Splints (4)  ·  Sugammadex (4)  ·  Donepezil (3)  ·  Eszopiclone (3)  ·  Modafinil (3)  ·  Budesonide (2)  ·  Drug Delivery Systems (2)  ·  Ketorolac (2)  ·  Mometasone Furoate (2)  ·  Neostigmine (2)  ·  Saline Solution (2)

Sponsors

University Hospital, Antwerp (4)  ·  University of California, San Diego (4)  ·  University of Sao Paulo (4)  ·  University of Chicago (3)  ·  University of Zurich (3)  ·  Associacao Fundo de Incentivo a Psicofarmcologia (2)  ·  Associação Fundo de Incentivo à Pesquisa (2)  ·  Children's Hospital Medical Center, Cincinnati (2)  ·  Emory University (2)  ·  Fédération Française de Pneumologie (2)  ·  Hospital de Clinicas de Porto Alegre (2)  ·  Inspire Medical Systems, Inc. (2)  ·  Peking University First Hospital (2)  ·  Regional Hospital Holstebro (2)  ·  University Hospital, Grenoble (2)

Countries

United States (35)  ·  Brazil (12)  ·  Belgium (7)  ·  Canada (7)  ·  China (4)  ·  France (4)  ·  Italy (4)  ·  Switzerland (4)  ·  Denmark (2)  ·  Germany (2)  ·  Netherlands (2)  ·  South Korea (2)  ·  Spain (2)  ·  Turkey (Türkiye) (2)  ·  Australia (1)

Top investigators

Konrad E Bloch, MD (3)  ·  Armin Steffen, PD Dr. med. (2)  ·  Christopher J Lettieri, MD (2)  ·  Clemens Heiser, Dr. med. (2)  ·  David L Steward, MD (2)  ·  Denis Martinez, MD, PhD (2)  ·  Erling B Pedersen, Professor (2)  ·  Olivier Vanderveken, MD, PhD (2)  ·  Alister Bates, PhD (1)  ·  Andrew Goldberg, MD (1)  ·  Andrew Wheeler, MD (1)  ·  Andrzej Tykarski, Prof (1)  ·  Bertram Pitt, MD (1)

Results publications

PMID 10450601, PMID 10678860, PMID 10908222, PMID 10940788, PMID 11208620, PMID 11422885, PMID 11587154, PMID 12748199, PMID 14500166, PMID 15187032, PMID 16376782, PMID 16494088, PMID 16579514, PMID 17452537, PMID 17494787, PMID 17496462, PMID 17556718, PMID 17920917, PMID 17921053, PMID 17936040, PMID 17975198, PMID 1798888, PMID 18172212, PMID 18198262, PMID 18292756, PMID 18347202, PMID 18404673, PMID 18413499, PMID 18452788, PMID 18458174, PMID 18539753, PMID 18584016, PMID 18595959, PMID 18647805, PMID 18663661, PMID 18710420, PMID 18788656, PMID 19101028, PMID 19171788, PMID 19225527, PMID 19249441, PMID 19357147, PMID 19567493, PMID 19920270, PMID 20016520, PMID 20051221, PMID 20411620, PMID 20448096, PMID 20522795, PMID 20642206

NIH funding

2019 (1), R01HL075079 (1), U19AI057229 (1)